Skip Navigation

VAERS Bibliography - December 2001

  1. Adamo, B., Coluccio, R., D'Apice, A., D'Argenio, P., Ferrara, M. A., Giugliano, F., Parrella, R., Peluso, F., Romeo, V., Ronga, C., and Simonetti, A. 
    Influenza vaccination coverage in elderly people, Campania (Italy), 1999  Euro.Surveill.  2001, 6 (2): 26-30.
  2. Allsup, S. J., Gosney, M., Regan, M., Haycox, A., Fear, S., and Johnstone, F. C. 
    Side Effects of Influenza Vaccination in Healthy Older People: A Randomised Single-Blind Placebo-Controlled Trial  Gerontology.  2001, 47 (6): 311-314.
  3. Ament, A., Fedson, D. S., and Christie, P. 
    Pneumococcal vaccination and pneumonia: even a low level of clinical effectiveness is highly cost-effective  Clin.Infect.Dis.  12-15-2001, 33 (12): 2078-2079.
  4. Barnfield, C., Brew, R., Tilling, R., Rae, A., Wheeler, C., and Klavinskis, L. S. 
    The cellular basis of immune induction at mucosal surfaces by DNA vaccination  Dev.Biol.(Basel).  2000, 104:159-64. (): 159-164.
  5. Cohen, J. 
    Bioterrorism. Smallpox vaccinations: how much protection remains?  Science.  11-2-2001, 294 (5544): 985.
  6. Cui, X. W., Nagao, M. M., and Effler, P. V. 
    Influenza and pneumococcal vaccination coverage levels among Hawaii statewide long-term-care facilities  Infect.Control Hosp.Epidemiol.  2001, 22 (8): 519-521.
  7. Davis, J. W., Lee, E., Taira, D. A., and Chung, R. S. 
    Influenza vaccination, hospitalizations, and costs among members of a medicare managed care plan  Med.Care.  2001, 39 (12): 1273-1280.
  8. DeStefano, F. and Chen, R. T. 
    Autism and measles-mumps-rubella vaccination: controversy laid to rest?  CNS.Drugs.  2001, 15 (11): 831-837.
  9. Fulton, J. P. 
    Asthma and flu vaccination  Med.Health R.I.  2001, 84 (10): 343.
  10. Gasior-Chrzan, B. 
    Delayed granulomatous lesion at the bacillus Calmette-Guerin vaccination site  Acta Derm.Venereol.  2001, 81 (4): 302-304.
  11. Goronzy, J. J., Fulbright, J. W., Crowson, C. S., Poland, G. A., O'Fallon, W. M., and Weyand, C. M. 
    Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals  J.Virol.  2001, 75 (24): 12182-12187.
  12. Heller, D. 
    Ethical debate: Vaccination against mumps, measles, and rubella: is there a case for deepening the debate? How safe is MMR vaccine?  BMJ.  10-13-2001, 323 (7317): 839-840.
  13. Johansson, E. L., Wassen, L., Holmgren, J., Jertborn, M., and Rudin, A. 
    Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans  Infect.Immun.  2001, 69 (12): 7481-7486.
  14. Kent, S. J., Dale, C. J., Preiss, S., Mills, J., Campagna, D., and Purcell, D. F. 
    Vaccination with attenuated simian immunodeficiency virus by DNA inoculation  J.Virol.  2001, 75 (23): 11930-11934.
  15. Kreft, B., Fischer, A., Kruger, S., Sack, K., Kirchner, H., and Rink, L. 
    The impaired immune response to diphtheria vaccination in elderly chronic hemodialysis patients is related to zinc deficiency  Biogerontology.  2000, 1 (1): 61-66.
  16. Kumar, V., Sercarz, E., Zhang, J., and Cohen, I. 
    T-cell vaccination: from basics to the clinic  Trends Immunol.  2001, 22 (10): 539-540.
  17. Liddle, B. J. and Jennings, R. 
    Influenza vaccination in old age  Age Ageing.  2001, 30 (5): 385-389.
  18. Mak, D. B., Plant, A. J., and Louise, Rushworth R. 
    Where the data are deficient: a field evaluation of the effectiveness of pneumococcal vaccination in remote Australia  Aust.J.Rural.Health.  2001, 9 (1): 38-46.
  19. Mas, Lago P., Caceres, V. M., Galindo, M. A., Gary, H. E., Jr., Valcarcel, M., Barrios, J., Sarmiento, L., Avalos, I., Bravo, J. A., Palomera, R., Bello, M., Sutter, R. W., Pallansch, M. A., and de Quadros, C. A. 
    Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication  Int.J.Epidemiol.  2001, 30 (5): 1029-1034.
  20. Muennig, P. A. and Khan, K. 
    Cost-Effectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults  Clin.Infect.Dis.  12-1-2001, 33 (11): 1879-1885.
  21. Opstelten, W., Hak, E., Verheij, T. J., and van Essen, G. A. 
    Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncompliance  Am.J.Med.  10-15-2001, 111 (6): 474-479.
  22. Pattison, S. 
    Ethical debate: Vaccination against mumps, measles, and rubella: is there a case for deepening the debate? How safe is MMR vaccine?  BMJ.  10-13-2001, 323 (7317): 840.
  23. Rodewald, L. E. and Santoli, J. M. 
    The challenge of vaccinating vulnerable children  J.Pediatr.  2001, 139 (5): 613-615.
  24. Russell, M. L. and Ferguson, C. A. 
    Using epidemiology to target staff influenza vaccination programs  Infect.Control Hosp.Epidemiol.  2001, 22 (8): 525-526.
  25. Schunk, M., Wachinger, W., and Wachinger, H. 
    Vaccination status and prophylactic measures of travelers from Germany to subtropical and tropical areas: results of an airport survey  J.Travel.Med.  2001, 8 (5): 260-262.
  26. Stephenson, J. 
    The World in Medicine: Smallpox Vaccination and the WHO  JAMA.  11-14-2001, 286 (18): 2225.
  27. Tantawichien, T., Tantawichien, T., Supit, C., Khawplod, P., and Sitprija, V. 
    Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis  Clin.Infect.Dis.  12-15-2001, 33 (12): 2085-2087.
  28. Traynor, K. 
    CDC has anthrax, smallpox vaccination guidelines available  Am.J.Health Syst.Pharm.  11-1-2001, 58 (21): 2008.
  29. van, der Lubben, I, Verhoef, J. C., Borchard, G., and Junginger, H. E. 
    Chitosan for mucosal vaccination  Adv.Drug Deliv.Rev.  11-5-2001, 52 (2): 139-144.
  30. Wallinga, J., Levy-Bruhl, D., Gay, N. J., and Wachmann, C. H. 
    Estimation of measles reproduction ratios and prospects for elimination of measles by vaccination in some Western European countries  Epidemiol.Infect.  2001, 127 (2): 281-295.